Magdalena Kegel,  —

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

Articles by Magdalena Kegel

Unmet Published Guidelines for CF-Related Diabetes Can Be ‘Incompletely Successful’, Study Shows

Because some cystic Fibrosis (CF) clinics often fail to follow published guidelines for the screening and care of diabetes in CF patients, but self-implemented ways can produce better patient outcomes, a recent study suggests that optimal care can differ from recommendations. CF-related diabetes is an increasingly common complication in CF patients, resulting in substantial…

CF Patients No Longer at High Risk for Thyroid Dysfunction, Study Finds

Goiter and hypothyroidism — conditions linked to thyroid gland problems — are no longer major concerns for patients with cystic fibrosis (CF), according to recent research showing that only a fraction of patients now have severe thyroid dysfunction, possibly mirroring lesser use of iodine-based drugs. The study, “Thyroid Function in…

Lung Exacerbations in Young CF Patients Linked to Poorer Quality of Life

Pulmonary exacerbations have a negative impact on the general health-related quality of life in people with cystic fibrosis (CF), a study reported, stressing the importance of preventing such flares in this group. Assessing general, as opposed to disease-specific, health-related quality of life measures are needed when comparing different disease conditions and determining the usefulness of…

CF Patient, 25, Reclaims His Life Through Rare Lungs-and-Liver Transplant at UT Southwestern

Two Texas surgical teams recently performed an extremely rare, lungs-and-liver double organ transplant at the University of Texas (UT) Southwestern Medical Center’s William P. Clements Jr. University Hospital. The operation, the first successfully completed in North Texas and only the 75th such surgery in the United States,  gave 25-year-old Josiah…

Natural Treatments of Little Benefit on Their Own to CF Patients, But Potential Seen for Drug Development

A Chicago Medical School review explored the scientific evidence behind three natural compounds — genistein, curcumin, and resveratrol — often proposed for the treatment of cystic fibrosis (CF). The review concluded that while the mechanisms by which these substances function should be further investigated as potential drug treatments, there is little evidence…

Pediatric CF Case Study Warns That Fungal Infections Can Be Mistaken for Plastic Bronchitis

Cystic fibrosis (CF) patients with a fungal infection caused by Scedosporium apiospermum may have a clinical presentation resembling plastic bronchitis. A case report presents this unusual scenario, alerting clinicians to consider such fungus infection when encountering similar cases. Plastic bronchitis is characterized by a dysfunctional flow of lymph fluid, leading to the…